Switch to:

OncoMed Pharmaceuticals Inc (OMED) Ownership Data

Short Interest History (%)

This is the historical short interest of OncoMed Pharmaceuticals Inc, as measured by the Short Percentage Of Float.

Date Short Interest (%)Short Interest (Shares in Mil)
November 15, 20169.792.16
October 31, 201610.12.22
October 14, 201610.112.23
September 30, 201610.292.27
September 15, 20169.742.15
August 31, 20169.051.99
August 15, 20169.762.15
July 29, 201610.452.30
July 15, 20168.871.95
June 30, 20169.242.04
June 15, 20168.521.88
May 31, 20167.81.72
May 13, 20167.541.66
April 29, 20166.071.34
April 15, 20167.021.37
March 31, 20168.031.57
March 15, 20168.071.57
February 29, 20168.561.67
February 12, 20169.491.85
January 29, 201611.62.26
January 15, 201611.392.22
December 31, 20159.831.92
December 15, 20159.481.85
November 30, 20159.391.83
November 13, 20158.931.74
October 30, 20159.241.80
October 15, 201510.842.11
September 30, 201511.112.17
September 15, 201511.712.29
August 31, 201511.772.30
August 14, 201510.812.11
July 31, 201510.161.98
July 15, 20159.321.82
June 30, 20158.911.74
June 15, 20159.271.81
May 29, 20159.121.78
May 15, 20158.791.72
April 30, 20158.291.62
April 15, 201513.491.78
March 31, 201513.251.75
March 13, 201513.881.83
February 27, 201514.511.92
February 13, 201516.022.12
January 30, 201517.892.36
January 15, 201520.542.71
December 31, 201420.232.67
December 15, 201421.922.90
November 28, 201422.412.96
November 14, 201422.773.01
October 31, 201423.323.08
October 15, 201421.852.89
September 30, 201420.732.74
September 15, 201418.282.41
August 29, 201416.712.21
August 15, 201415.92.10
July 31, 201416.372.16
July 15, 201416.322.16
June 30, 201413.941.84
June 13, 201414.561.92
May 30, 201414.661.94
May 15, 201415.442.04
April 30, 201415.842.09
April 15, 201423.762.25
March 31, 201421.62.04
March 14, 201422.042.08
February 28, 201421.672.05
February 14, 201421.422.03
January 31, 201419.011.80
January 15, 201419.511.84
December 31, 201318.371.74
December 13, 201315.21.44
November 29, 201313.811.31
November 15, 201312.021.14
October 31, 201311.171.06
October 15, 20139.360.88
September 30, 20138.250.78
September 13, 20136.560.62
August 30, 20136.430.61
August 15, 20135.620.53
July 31, 20132.890.27

Institutional Ownership History (%)

This the Institutional Ownership History of OncoMed Pharmaceuticals IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership (%)Institutional Ownership (Shares in Mil)
September 30, 201641.1415.25
June 30, 201637.4111.37
March 31, 201641.0912.46
December 31, 201550.4115.18
September 30, 201536.410.54
June 30, 201535.8810.79
March 31, 201534.1410.24
December 31, 201479.4823.72
September 30, 201426.157.79
June 30, 201422.996.84
March 31, 201420.816.15
December 31, 201376.622.52
September 30, 201315.854.41

Insider ownership (%)

This is the historical insider ownership of OncoMed Pharmaceuticals Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership (%)Insider Ownership (Shares in Mil)
October 31, 20161.060.32
September 30, 20161.060.32
August 31, 20161.060.32
July 31, 20161.070.32
June 30, 20161.070.32
May 31, 20161.070.32
April 30, 20161.070.32
March 31, 20160.970.29
February 29, 20160.980.29
January 31, 20160.980.29
December 31, 20150.970.29
November 30, 20151.020.31
October 31, 201510.30
September 30, 20151.040.31
August 31, 20150.960.29
July 31, 20150.960.29
June 30, 20151.010.30
May 31, 20151.010.30
April 30, 20151.030.31
March 31, 20151.040.31
February 28, 20151.050.31
January 31, 20151.060.32
December 31, 20140.660.20
November 30, 20141.010.30
October 31, 20141.030.31
September 30, 20141.040.31
August 31, 20141.050.31
July 31, 20140.950.28
June 30, 20140.970.29
May 31, 20140.980.29

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Jack W. LasersohnN/A77,0870.21%2016-10-10
Dr. Jonathan D. Root,M.D.N/A65,0910.18%2015-11-30
Dr. Timothy Hoey, PhDSVP, Cancer Biology & Co-CSO60,9790.16%2016-11-16
Dr. Austin Gurney, PhDSee Remarks47,0550.13%2016-10-09
Paul J. HastingsChairman & CEO37,3230.1%2016-10-09
Dr. Jakob Dupont, M.D.SVP & Chief Medical Officer34,440less than 0.1%2016-10-09
Dr. John A. Lewicki, PhDEVP & Chief Scientific Officer31,636less than 0.1%2016-10-09
Mr. Sunil PatelSee Remarks30,338less than 0.1%2016-10-09
Dr. Alicia J. Hager, PhDVP & General Counsel25,877less than 0.1%2016-10-09
Dr. Laurence Lasky, PhDN/A10,332less than 0.1%2015-11-30

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
PRIMECAP Management Company Premium1,302,7002016-09-303.510.0114,890
BlackRock Fund Advisors   Premium Plus1,072,1712016-09-302.89N/A12,255
Fidelity Management and Research Company   Premium Plus911,3032016-09-302.46N/A10,416
Bvf Inc   Premium Plus1,812,0052016-09-304.893.9020,711
Adams Street Partners LLC   Premium Plus1,839,7302016-06-306.053.6522,647
Celgene Corp2,970,5882016-08-239.69N/A36,033
Morgenthaler Management Partners VII, LLC2,509,6722015-12-318.33N/A56,568
Presidio Management Group VIII, L.L.C.2,038,2722015-12-316.77N/A45,943
Vertical Group Lp1,910,0272016-03-176.31N/A18,203
PrimeCap Odyssey Aggressive Growth Fund1,246,8002016-09-303.360.2014,251

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK